Integer Holdings Corp. hires SVPs from Solventum and Brink’s

Integer Holdings Corp. has added two new SVPs to the contract development and manufacturing organization’s executive leadership team (ELT).

The company hired Lindsay Krause Blackwood as SVP, general counsel, corporate secretary and chief ethics and compliance officer. She replaces Mac Marshall, who retired from the position at the end of March.

Integer also hired Sanjiv Arora as SVP of strategy, business development and investor relations to replace Andrew Senn, who was promoted to serve as president of Integer’s Cardio & Vascular business.

The two new hires will report to President and CEO Joe Dziedzic, who described them as “exemplary leaders.”

“Their collective experience and critical knowledge of the medical device industry not only complement our existing ELT, but further enhance our expertise in corporate strategy and governance, M&A and enterprise risk management, all of which are critical as we continue to execute on our strategy,” he said in a news release.

Blackwood was most recently EVP, general counsel, chief compliance officer and corporate secretary for The Brink’s Co. and previously held legal roles at Cigna Corp., Verizon Business (formerly known as MCI Inc.), and law firms Shaw Pittman (now Pillsbury Winthrop Shaw Pittman) and Gibson Dunn & Crutcher.

Arora was previously SVP and chief strategy and corporate development officer for Solventum and also held senior leadership roles at Medtronic, Edwards Lifesciences, Covidien and Boston Scientific. He was formerly a managing director at Cargill and RBC Capital Markets focused on healthcare technology research, life sciences and medical technology investments.

Plano, Texas-based Integer is one of the largest CDMOs in medtech, working with medical device OEMs on cardiac rhythm management, neuromodulation, and cardio and vascular devices. It’s the world’s 57th-largest medical device company, according to Medical Design & Outsourcing‘s 2024 Medtech Big 100 ranking by revenue.